GLP-1 Drugs Can Be Used First for Weight Loss, Says American College of Cardiology

GLP-1 reduced migraine frequency by nearly half, in a pilot study

GLP-1 drugs like semaglutide being studied for more than just weight loss. Scientist calls this pilot study 'hugely interesting,' said more research needed.

Watch GLP-1s Should Be Treatment for Heart Disease, ACC Says

GLP-1 Drugs Can Be Used First for Weight Loss, Says American College of Cardiology

(MedPage Today) -- The American College of Cardiology (ACC) gave popular obesity medications equal standing with diet and exercise as a first-line strategy for weight management. In new concise clinical guidance, the ACC promoted current-generation...

Weight-loss drugs should be first step to prevent heart disease, top cardiology group says

Millions more Americans should be taking weight-loss drugs to prevent heart disease, according to the American College of Cardiology.

9 Questions to Ask Your Doctor About Compounded GLP-1 Drugs

The U.S. Food and Drug Administration (FDA) recently announced that compounded GLP-1 weight loss drugs — copies of blockbuster brand-name weight loss and diabetes meds semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — would no longer be available. Compounded versions of drugs are not regulated or tested by the FDA.e60dc2a1-f33c-4a05-9b50-8e3e8e5976298d51e61d-d5cb-44b5-af15-90b30cc99e46 Despite the so-called ban, compounded GLP…

ACC endorses first-line use of GLP-1s for heart health – RamaOnHealthcare

The American College of Cardiology has recommended that physicians embrace weight loss medications, such as semaglutide and tirzepatide, as first-line